Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Directors Interest

(99% Neutral) SHAKE SHACK INC. (SHAK) Files Form 8-K

(99% Neutral) NEXMETALS MINING CORP. (NEXM) Files Form 8-K

(30% Negative) ENTRADA THERAPEUTICS, INC. (TRDA) Reports Q2 2026 Financial Results

(19% Negative) BIGCOMMERCE HOLDINGS, INC. (CMRC) Reports Q2 2026 Financial Results

Employee Stock Option/ Share Scheme: Notice of Transfer and Use of Treasury Shares

(90% Positive) ENGENE HOLDINGS INC. (ENGNW) Announces Clinical Development Update

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

(90% Positive) ARMATA PHARMACEUTICALS, INC. (ARMP) Provides Update on need for AP-SA02 Enables more frequent FDA engagement

(99% Positive) REGAL REXNORD CORP (RRX) Reports Q2 2026 Financial Results

(10% Negative) IRONWOOD PHARMACEUTICALS INC (IRWD) Reports Q2 2026 Financial Results

(30% Negative) XOMETRY, INC. (XMTR) Reports Q2 2026 Financial Results

(90% Positive) SCHOLAR ROCK HOLDING CORP (SRRK) Announces Enrollment Update for supply Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(30% Negative) NEUMORA THERAPEUTICS, INC. (NMRA) Reports Q2 2026 Financial Results

Entrada Therapeutics Reports First Quarter 2026 Financial Results